TELA BioTELA -4.00%52 Pretax Margin % is -64.08% as of Mar. 2026. GuruFocus rates TELA with a GF Score™ of 52/100 and a GF Value™ of $1.66 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 816 Medical Devices & Instruments companies, TELA Bio ranks worse than 75.37% on this metric.
Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. TELA Bio's Pre-Tax Income for the
three
months ended in Mar. 2026 was $-12.21 Mil. TELA Bio's Revenue for the
three
months ended in Mar. 2026 was $19.06 Mil. Therefore, TELA Bio's pretax margin for the quarter that ended in Mar. 2026 was -64.08%.
The historical rank and industry rank for TELA Bio's Pretax Margin % or its related term are showing as below:
TELA'
s Pretax Margin % Range Over the Past 10 Years
Min: -502.57 Med: -112.94 Max: -48.09
Current: -49
TELA's Pretax Margin % is ranked worse than 75.37% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: 2.505
vs TELA: -49.00
TELA Bio (NAS:TELA) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
TELA Bio Pretax Margin % Related Terms
TELA Bio Pretax Margin % Historical Data
* Premium members only.
The historical data trend for TELA Bio's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TELA vs NSPR, BDMD, PAVM: Pretax Margin % Comparison
For the Medical Devices subindustry, TELA Bio's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TELA Bio Pretax Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, TELA Bio's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where TELA Bio's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TELA Bio (TELA) has a Pretax Margin % of -64.08% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on TELA Bio and its competitors. According to the industry distribution chart, TELA Bio ranks #615 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 75.4%.
Is TELA Bio's Pretax Margin % too high?
TELA Bio's current Pretax Margin % is -64.08%. Based on the distribution chart, TELA Bio ranks #615 out of 816 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, TELA Bio has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does TELA Bio's Pretax Margin % compare to NSPR and BDMD?
According to the Medical Devices & Instruments industry distribution chart, TELA Bio ranks #615 out of 816 companies for Pretax Margin %. This places TELA Bio in the lower half of its industry. The industry median Pretax Margin % is 2.51. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Devices & Instruments company?
The median Pretax Margin % among Medical Devices & Instruments companies is 2.51, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on TELA Bio and its competitors. For the Medical Devices & Instruments industry, the median Pretax Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TELA Bio's current Pretax Margin % is -64.08%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TELA Bio stock overvalued right now?
Based on GuruFocus' analysis, TELA Bio (TELA) is currently considered Possible Value Trap. The stock's GF Value™ is $1.66, compared to a current price of $0.72 — trading 56.6% below its estimated fair value. The current Pretax Margin % is -64.08%. TELA Bio's overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For TELA Bio (TELA), the current Pretax Margin % is -64.08% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TELA Bio (TELA) Overvalued in 2026?
Based on GuruFocus' analysis, TELA Bio stock appears to be undervalued.
The current stock price of $0.72 is trading 56.6% below its estimated GF Value™ of $1.66.
GuruFocus considers TELA Bio to be Possible Value Trap.
Key valuation signals for TELA:
Pretax Margin %: -64.08%
GF Value™: $1.66 vs. price of $0.72 (56.6% below fair value)
No single metric tells the full story. See the TELA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TELA Bio Inc a commercial-stage medical technology company focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
52GF Score
Get the complete analysis for TELA
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TELA has been successfully added to your 
